Himachal Pradesh cracks down on NSQ Drugs Manufacturers

The inspections have led to action against 116 companies found to be producing NSQ drugs.

166
NSQ Drugs
NSQ Drugs

Last Updated on December 14, 2024 by The Health Master

NSQ Drugs

Himachal Pradesh, a major pharmaceutical hub in India, has taken significant strides to ensure the quality and affordability of medicines for its citizens. The Himachal Pradesh Drugs Control Administration (HP DCA) has been actively working to identify and penalize pharmaceutical companies producing not of standard quality (NSQ) drugs.

Joint Inspections and Strict Action

Between January 2023 and October 2024, the HP DCA conducted 142 joint inspections with central authorities to scrutinize the manufacturing processes of pharmaceutical companies.

These inspections have led to action against 116 companies found to be producing NSQ drugs.

Penalties for Non-Compliance

The state health minister, Col. Dhani Ram Shandil (Retd.), announced that the following actions were taken against the erring companies:

  • Manufacturing Suspension: The production of the identified NSQ drugs was halted for a period of one to two months.
  • Legal Proceedings: Legal actions were initiated against the companies in the respective jurisdictions.
  • Process Review and Rectification: The companies were directed to review and rectify their manufacturing processes to ensure future compliance with quality standards.

Himachal Pradesh: A Leader in Drug Quality

Himachal Pradesh contributes significantly to India’s pharmaceutical industry, accounting for 33% of the country’s total medicine production.

The state has consistently maintained a lower rate of NSQ drugs compared to the national average.

According to a survey by the Health Ministry, the national percentage of NSQ drugs is 3.16%, while Himachal Pradesh’s figure over the past three years is only 1.22%.

Transparency and Public Awareness

To ensure transparency and public awareness, the state government regularly shares data on NSQ drugs with the Central Drugs Standard Control Organization (CDSCO).

This information is also made available on the CDSCO’s website.

Key Takeaways:

  • Himachal Pradesh has a strong regulatory framework for drug manufacturing.
  • The state government is committed to ensuring the availability of quality and affordable medicines.
  • Strict action is taken against companies producing NSQ drugs.
  • Transparency and public awareness are key to ensuring drug safety.

What is the role of the Drugs Control Administration (DCA)?

The DCA is responsible for regulating the manufacturing, sale, and distribution of drugs in Himachal Pradesh. It conducts inspections, enforces drug laws, and takes action against companies violating regulations.

Why is Himachal Pradesh taking strict action against NSQ drug manufacturers?

The state government is committed to ensuring the availability of safe and affordable medicines for its citizens. By taking stringent action against NSQ drug manufacturers, the government aims to protect public health.

How can consumers ensure they are purchasing quality medicines?

Consumers should always purchase medicines from licensed pharmacies and check the expiry date and batch number on the packaging. They should also report any adverse drug reactions to the appropriate authorities.

Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news